Legend Biotech Corporation Sponsored ADR (LEGN)

Last Closing Price: 28.97 (2025-05-29)

Earnings Announcements: Estimated vs Actual

On 2025-05-13, Legend Biotech Corporation Sponsored ADR (LEGN) announced earnings per share of $-0.07 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.40.

The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-0.18 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-13 2025-03-31 $-0.40 $-0.07
2025-03-11 2024-12-31 $-0.39 $-0.15
2024-11-12 2024-09-30 $-0.56 $-0.34
2024-08-09 2024-06-30 $-0.54 $-0.05
2024-05-13 2024-03-31 $-0.29 $-0.16
2024-03-11 2023-12-31 $-0.70 $-0.40
2023-11-20 2023-09-30 $-0.56 $-0.17
2023-08-15 2023-06-30 $-0.69 $-0.27
2023-05-18 2023-03-31 $-0.56 $-0.40
2023-02-17 2022-06-30 -- $-0.41
2022-06-01 2022-03-31 $-0.37 $-0.24
2022-03-18 2021-12-31 $-0.35 $-0.38
2021-11-16 2021-09-30 $-0.35 $-0.43
2021-08-23 2021-06-30 $-0.31 $-0.32
2021-05-18 2021-03-31 $-0.38 $-0.30
2021-03-18 2020-12-31 $-0.28 $-0.22
2020-11-16 2020-09-30 $-0.31 $-0.25
2020-08-28 2020-06-30 $-0.26 $-0.26